95 related articles for article (PubMed ID: 16170697)
1. [Prostate neoplasms--tumor grading and magnetic resonance spectroscopy].
Rofo; 2005 Oct; 177(10):1342. PubMed ID: 16170697
[No Abstract] [Full Text] [Related]
2. Clinical efficacy of proton magnetic resonance spectroscopy (1H-MRS) in the diagnosis of localized prostate cancer.
Saito K; Kaminaga T; Muto S; Ide H; Nishio K; Kamiyama Y; Okada H; Terado Y; Furui S; Horie S
Anticancer Res; 2008; 28(3B):1899-904. PubMed ID: 18630478
[TBL] [Abstract][Full Text] [Related]
3. Editorial comment on: role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.
Hara N
Eur Urol; 2008 Sep; 54(3):598-9. PubMed ID: 18226440
[No Abstract] [Full Text] [Related]
4. Editorial comment on: role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.
Fütterer JJ; Barentsz JO
Eur Urol; 2008 Sep; 54(3):599-600. PubMed ID: 18226439
[No Abstract] [Full Text] [Related]
5. Phased array magnetic resonance imaging for staging clinically localised prostrate cancer.
Borre M; Lundorf E; Marcussen N; Langkilde NC; Wolf H
Acta Oncol; 2005; 44(6):589-92. PubMed ID: 16294442
[TBL] [Abstract][Full Text] [Related]
6. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.
Sciarra A; Panebianco V; Salciccia S; Osimani M; Lisi D; Ciccariello M; Passariello R; Di Silverio F; Gentile V
Eur Urol; 2008 Sep; 54(3):589-600. PubMed ID: 18226441
[TBL] [Abstract][Full Text] [Related]
7. Percent tumor involvement and risk of biochemical progression after radical prostatectomy.
Rampersaud EN; Sun L; Moul JW; Madden J; Freedland SJ
J Urol; 2008 Aug; 180(2):571-6; discussion 576. PubMed ID: 18554662
[TBL] [Abstract][Full Text] [Related]
8. Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostate.
Fütterer JJ; Scheenen TW; Heijmink SW; Huisman HJ; Hulsbergen-Van de Kaa CA; Witjes JA; Heerschap A; Barentsz JO
Invest Radiol; 2007 Feb; 42(2):116-22. PubMed ID: 17220729
[TBL] [Abstract][Full Text] [Related]
9. [Staging of prostate cancer: value of the combined information of endorectal MRI, biopsy Gleason score, and preoperative PSA level].
Wetter A; Ajdukovic AN; Fliessbach K; Lehnert T; Engl T; Jacobi V; Vogl TJ
Rofo; 2006 Apr; 178(4):385-90. PubMed ID: 16607587
[TBL] [Abstract][Full Text] [Related]
10. Substaging pathologically organ confined (pT2) prostate cancer: an exercise in futility?
van der Kwast TH
Eur Urol; 2006 Feb; 49(2):209-11. PubMed ID: 16417961
[No Abstract] [Full Text] [Related]
11. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
[TBL] [Abstract][Full Text] [Related]
12. Proton spectroscopic and dynamic contrast-enhanced magnetic resonance: a modern approach in prostate cancer imaging.
Sciarra A; Salciccia S; Panebianco V
Eur Urol; 2008 Sep; 54(3):485-8. PubMed ID: 18439748
[No Abstract] [Full Text] [Related]
13. Endorectal MR imaging before salvage prostatectomy: tumor localization and staging.
Sala E; Eberhardt SC; Akin O; Moskowitz CS; Onyebuchi CN; Kuroiwa K; Ishill N; Zelefsky MJ; Eastham JA; Hricak H
Radiology; 2006 Jan; 238(1):176-83. PubMed ID: 16373766
[TBL] [Abstract][Full Text] [Related]
14. Improved accuracy for predicting the Gleason score of prostate cancer by increasing the number of transrectal biopsy cores.
Miyake H; Kurahashi T; Takenaka A; Hara I; Fujisawa M
Urol Int; 2007; 79(4):302-6. PubMed ID: 18025846
[TBL] [Abstract][Full Text] [Related]
15. Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate Cancer.
Naito S; Kuroiwa K; Kinukawa N; Goto K; Koga H; Ogawa O; Murai M; Shiraishi T;
J Urol; 2008 Sep; 180(3):904-9; discussion 909-10. PubMed ID: 18635221
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer: local staging at 3-T endorectal MR imaging--early experience.
Fütterer JJ; Heijmink SW; Scheenen TW; Jager GJ; Hulsbergen-Van de Kaa CA; Witjes JA; Barentsz JO
Radiology; 2006 Jan; 238(1):184-91. PubMed ID: 16304091
[TBL] [Abstract][Full Text] [Related]
17. The relationship between tumor volume and the number of positive cores in men undergoing multisite extended biopsy: implication for expectant management.
Ochiai A; Troncoso P; Chen ME; Lloreta J; Babaian RJ
J Urol; 2005 Dec; 174(6):2164-8, discussion 2168. PubMed ID: 16280756
[TBL] [Abstract][Full Text] [Related]
18. Editorial comment on: Prostate-specific antigen improves the ability of clinical stage and biopsy gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.
Stenman UH
Eur Urol; 2007 Oct; 52(4):1074-5. PubMed ID: 17383813
[No Abstract] [Full Text] [Related]
19. Percentage of cancer in prostate biopsies as prognostic factor for staging and postoperative biochemical failure after radical prostatectomy.
Villamón-Fort R; Martínez-Jabaloyas JM; Soriano-Sarriá P; Ramos-Soler D; Pastor-Hernández F; Gil-Salom M
Urol Int; 2007; 78(4):328-33. PubMed ID: 17495491
[TBL] [Abstract][Full Text] [Related]
20. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings.
Villers A; Puech P; Mouton D; Leroy X; Ballereau C; Lemaitre L
J Urol; 2006 Dec; 176(6 Pt 1):2432-7. PubMed ID: 17085122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
